These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9645808)

  • 21. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries.
    Qian Z; Hu W; Liu J; Sanfilippo F; Hruban RH; Baldwin WM
    Transplantation; 2001 Sep; 72(5):900-6. PubMed ID: 11571457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
    J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
    Yang CP; Shittu E; Bell EB
    J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD80/CD86 costimulation regulates acute vascular rejection.
    Hosiawa KA; Wang H; DeVries ME; Garcia B; Liu W; Zhou D; Akram A; Jiang J; Sun H; Cameron MJ; Zhong R; Kelvin DJ
    J Immunol; 2005 Nov; 175(9):6197-204. PubMed ID: 16237117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model.
    Smith CR; Mohanakumar T; Shimizu Y; Yu S; Otomo N; Kaleem Z; Flye MW
    Transplantation; 2000 Jan; 69(2):294-9. PubMed ID: 10670641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine regulation of chronic cardiac allograft rejection: evidence against a role for Th1 in the disease process.
    Piccotti JR; Li K; Chan SY; Eichwald EJ; Bishop DK
    Transplantation; 1999 Jun; 67(12):1548-55. PubMed ID: 10401761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection.
    Rolls HK; Kishimoto K; Dong VM; Illigens BM; Sho M; Sayegh MH; Benichou G; Fedoseyeva EV
    Transplantation; 2002 Oct; 74(7):1053-7. PubMed ID: 12394855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine.
    Wang H; Jiang J; Liu W; Kubelik D; Chen G; Gies D; Garcia B; Zhong R; Rother RP
    Transplantation; 2005 May; 79(9):1121-7. PubMed ID: 15880054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism.
    Zhang Z; Kaptanoglu L; Haddad W; Ivancic D; Alnadjim Z; Hurst S; Tishler D; Luster AD; Barrett TA; Fryer J
    J Immunol; 2002 Apr; 168(7):3205-12. PubMed ID: 11907073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astilbin suppresses acute heart allograft rejection by inhibiting maturation and function of dendritic cells in mice.
    Zou S; Shen X; Tang Y; Fu Z; Zheng Q; Wang Q
    Transplant Proc; 2010 Nov; 42(9):3798-802. PubMed ID: 21094859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection.
    Bumgardner GL; Li J; Prologo JD; Heininger M; Orosz CG
    Transplantation; 1999 Aug; 68(4):555-62. PubMed ID: 10480416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway.
    Wu T; Sun C; Chen Z; Zhen Y; Peng J; Qi Z; Yang X; Zhao Y
    J Immunol; 2012 Nov; 189(10):4989-5000. PubMed ID: 23045614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.